Tumor Marker Kinetics
DISEASE
Serum CEA was positive in 7 patients (JHU-002, 009, 005, 007, 014, 015, 016) and increased over time in 3 patients at doses of 150 and 300 mg, and was stable over time in 2 patients with doses of 600 and 900 mg; the remaining 2 patients had baseline CEA level only (Serum cytokines, chemokines and growth factors were analyzed. The percent change for all the analytes was calculated by normalizing them to respective baseline levels. Chemokines, cytokines, and growth factors in patients showing stable disease. Note: Serum cytokine/chemokine/growth factor profiling. 